Aurobindo Pharma's Board has approved a share buyback of up to 54,23,728 shares at INR 1,475 each, amounting to 800 Cr. This buyback, representing 0.93% of the paid-up capital, will be via a tender offer. The company has set April 17, 2026, as the record date. Only shareholders who hold shares on this date will be eligible to participate in the buyback offer.